Thrombosis in pregnancy: maternal and fetal issues
- 1 April 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 353 (9160), 1258-1265
- https://doi.org/10.1016/s0140-6736(98)10265-9
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Increased thrombin generation in women with recurrent miscarriageThe Lancet, 1998
- Puerperal thromboprophylaxis: comparison of the anti‐Xa activity of enoxaparin and unfractionated heparinBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Activated protein C resistance and adverse pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1997
- Preeclampsia is associated with a reduced response to activated protein CAmerican Journal of Obstetrics and Gynecology, 1997
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Resistance to activated protein C due to a factor V gene mutation: The most common inherited risk factor of thrombosisTrends in Cardiovascular Medicine, 1996
- Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancyBlood Coagulation & Fibrinolysis, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Thrombosis prophylaxis in obstetrics and gynaecologyBJOG: An International Journal of Obstetrics and Gynaecology, 1993